☆ 4.1 Review

A review of the role of CpG oligodeoxynucleotides as toll-like receptor 9 agonists in prophylactic and therapeutic vaccine development in infectious diseases

DRUGS IN R&D (2008)

Related references

Note: Only part of the references are listed.
Article Immunology

Adjuvant effect of CpG-Oligodeoxynucleotide in anti-fungal chemotherapy against fatal infection with Cryptococcus neoformans in mice

Takeshi Kinjo et al.

MICROBIOLOGY AND IMMUNOLOGY (2007)

Add to Collection
Article Immunology

CpG oligodeoxynucleotides protect normal and SIV-infected macaques from Leishmania infection

D Verthelyi et al.

JOURNAL OF IMMUNOLOGY (2003)

Add to Collection
Article Immunology

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

G Hartmann et al.

JOURNAL OF IMMUNOLOGY (2000)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.